Min Li to Proteomics
This is a "connection" page, showing publications Min Li has written about Proteomics.
Connection Strength
0.339
-
Targeted therapies for cancer. BMC Med. 2022 03 11; 20(1):90.
Score: 0.170
-
Serum Monitoring and Phenotype Identification of Stage I Non-Small Cell Lung Cancer Patients. Cancer Invest. 2017 Oct 21; 35(9):573-585.
Score: 0.125
-
EZH2 interacts with HP1BP3 to epigenetically activate WNT7B that promotes temozolomide resistance in glioblastoma. Oncogene. 2023 02; 42(6):461-470.
Score: 0.045